000 | 01828 a2200529 4500 | ||
---|---|---|---|
005 | 20250514222309.0 | ||
264 | 0 | _c20050830 | |
008 | 200508s 0 0 eng d | ||
022 | _a0006-8993 | ||
024 | 7 |
_a10.1016/j.brainres.2005.01.064 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHosoi, Rie | |
245 | 0 | 0 |
_aMicroPET detection of enhanced 18F-FDG utilization by PKA inhibitor in awake rat brain. _h[electronic resource] |
260 |
_bBrain research _cMar 2005 |
||
300 |
_a199-202 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Validation Study | ||
650 | 0 | 4 |
_aAnesthetics _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
650 | 0 | 4 |
_aBrain Mapping _xmethods |
650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
650 | 0 | 4 |
_aCyclic AMP _xanalogs & derivatives |
650 | 0 | 4 |
_aFluorodeoxyglucose F18 _xmetabolism |
650 | 0 | 4 |
_aFrontal Lobe _xdrug effects |
650 | 0 | 4 |
_aFunctional Laterality _xphysiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 | _aModels, Animal |
650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aThalamus _xdrug effects |
650 | 0 | 4 |
_aThionucleotides _xpharmacology |
650 | 0 | 4 |
_aWakefulness _xdrug effects |
700 | 1 | _aMatsumura, Akira | |
700 | 1 | _aMizokawa, Shigekazu | |
700 | 1 | _aTanaka, Masaaki | |
700 | 1 | _aNakamura, Fusao | |
700 | 1 | _aKobayashi, Kaoru | |
700 | 1 | _aWatanabe, Yasuyoshi | |
700 | 1 | _aInoue, Osamu | |
773 | 0 |
_tBrain research _gvol. 1039 _gno. 1-2 _gp. 199-202 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2005.01.064 _zAvailable from publisher's website |
999 |
_c15452971 _d15452971 |